Haifeng Lian

Dr. Haifeng Lian


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
HLHaifeng Lian
Haifeng Lian
CLChengxia Liu
Chengxia Liu
MLMing Li
Ming Li
YHYingbin Hu
Yingbin Hu
NSNing Shi
Ning Shi
HLHaiyan Liu
Haiyan Liu
Increasing evidence suggests that microRNAs are associated with many important biologic processes in carcinogenesis. Despite ample research revealing the dysregualtion of miR-486-5p in various cancers, little is known about the roles of miR-486-5p in colorectal carcinoma (CRC). In this study, we investigated the biological functions and molecular mechanisms of miR-486-5p in CRC growth and invasion, discussing the potential of using miR-486-5p as a biomarker for colorectal cancers. Our data revealed that miR-486-5p was significantly downregulated in CRC tissues compared with the paracancer tissue by quantitative real-time polymerase chain reaction and that miR-486-5p was downregulated to a greater extent in advanced stage cancer (stage III and IV) as compared to early stage cancer (stage I and II). Luciferase reporter assay verified that neuropilin-2 was a direct functional target of miR-486-5p in the CRC cells, and upregulation of miR-486-5p in CRC cells negatively correlated with the expression of neuropilin-2. Furthermore, overexpression of miR-486-5p inhibited the tumor growth and lymphangiogenesis in nude mice, which was reversed by overexpression of neuropilin-2. Taken together, our study suggested miR-486-5p might be a suppressor of CRC.

22 February 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
HLHaifeng Lian
Haifeng Lian
XZXiaoying S. Zhong
Xiaoying S. Zhong
YXYing Xiao
Ying Xiao
ZSZhe Sun
Zhe Sun
YSYuanyuan Shen
Yuanyuan Shen
QLQingjie Li
Qingjie Li
Background and Aims: While the interplay between heart and gut in inflammatory bowel disease (IBD) has previously been noted, how the inflamed gut impairs heart function remain elusive. We hypothesized that exosomal miRNAs of gut origin induce cardiac remodeling in IBD. Our aim was to identify plasma exosomal miRNAs that not only are of diagnostic value but also contribute to cardiac remodeling in patients with ulcerative colitis (UC).Methods: Plasma exosomes were isolated from UC patients and healthy control subjects and exosomal miRNAs were profiled by next-generation sequencing. Exosomal miR-29b levels in CCD841 CoN colon epithelial cells were detected by RT-qPCR. Exosomes packaged with miR-29b were incubated with H9c2 cells or administered to live mice.Results: The plasma exosomal miRNA profiles of the UC patients were significantly different from that of the controls and 20 miRNAs including miR-29b were differentially expressed. In CCD841 CoN cells, TNFα, IL-1β, and H2O2 significantly elevated miR-29b in both the cells and their secreted exosomes (p < 0.01), suggesting that intestinal epithelium secrets exosomes rich in miR-29b in IBD. In H9c2 myoblast cells, miR-29b modulated multiple genes including brain-derived neurotrophic factor (BDNF). Epithelial cell-derived exosomes packaged with miR-29b also attenuated BDNF and increased cleaved caspase 3, suggestive of apoptosis. Furthermore, tail vein injection of engineered exosomes with high levels of miR-29b suppressed BDNF and augmented cleaved caspase 3 in the heart of adult mouse (p < 0.01).Conclusion: Plasma exosomal miRNA profile could be a novel diagnostic approach for IBD. Excessive plasma exosomal miR-29b suppresses critical proteins like BDNF in IBD, leading to cardiac impairment.

19 February 2024 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
XGXiaolong Ge
Xiaolong Ge
HLHuaying Liu
Huaying Liu
YWYan Wu
Yan Wu
WLWei Liu
Wei Liu
WQWeilin Qi
Weilin Qi
WZWei Zhou
Wei Zhou

2 March 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
QLQiongyu Li
Qiongyu Li
FMFantao Meng
Fantao Meng
XMXiangxian Ma
Xiangxian Ma
ZSZhe Sun
Zhe Sun
JDJuanjuan Dai
Juanjuan Dai
HLHaifeng Lian
Haifeng Lian
Comorbidities due to inflammatory bowel disease (IBD) and anxiety are commonly acknowledged; however, their underlying basis is unclear. In the current study, we first conducted a clinical retrospective analysis to identify the enhancive incidence rate of IBD before or after the epidemic of Corona Virus Disease 2019 (COVID-19), with higher Generalized Anxiety Disorder-7 (GAD-7), as well as poorer Gastrointestinal Quality of Life Index (GIQLI). Then, the dextran sodium sulfate (DSS) and chronic unpredictable stress (CUS)-induced IBD and anxiety comorbid models were established with the correlational relations between symptoms of IBD and anxiety-related behaviors. We found dysfunctional up-regulation of a new inflammatory factor interleukin (IL)-19 in the colon of DSS/CUS treated mice. Overexpression of IL-19 in colon induced anxious phenotypes, and accelerated the anxious condition and symptoms of colitis in the DSS/CUS model by promoting the expression of inducible nitric oxide synthase (iNOS), IL-1β, and IL-6 pro-inflammatory factors, and activating signal transducer and activator of transcription 3 (STAT3) signaling pathway in the colon. Furthermore, overexpression of IL-19 in the colon also reduced the expression levels of brain-derived neurotrophic factor (BDNF), extracellular signal-regulated kinase (ERK), and cAMP-response element binding protein (CREB) signaling pathways activity in the hippocampus. These results suggest that IL-19 was a pivotal player in DSS/CUS-induced comorbidities of colitis and anxiety with different signaling pathways for the colon and hippocampus, which provides a candidate gene to explore the pathophysiology of comorbidities due to colitis and anxiety.

8 February 2026 in Medcomm
Verified
Journal Article
Open access
DKDengfeng Kang
Dengfeng Kang
ALAi Li
Ai Li
XXXiangqi Xie
Xiangqi Xie
HLHan Liu
Han Liu
LCLiang Chen
Liang Chen
ZLZhanju Liu
Zhanju Liu
Neutrophils significantly accumulate within the inflamed intestinal mucosa of patients with inflammatory bowel disease (IBD), where the farnesoid X receptor (FXR) is typically downregulated. However, the mechanisms by which FXR modulates neutrophil‐mediated mucosal inflammation in IBD remain elusive. Here, we demonstrated that FXR expression is markedly decreased in neutrophils from patients with active IBD. Fxr −/− mice exhibited exacerbated colitis following DSS insults or Citrobacter rodentium infection, evidenced by heightened neutrophil‐driven immune responses including increased neutrophil infiltration and neutrophil extracellular trap (NET) formation. Adoptive transfer of Fxr −/− neutrophils into WT recipients exacerbated DSS‐induced intestinal inflammation, indicating that FXR suppresses the pathogenic activity of neutrophils in a neutrophil‐intrinsic manner. An ex vivo functional assay revealed that Fxr −/− neutrophils display elevated ROS production, NET formation, and migratory capacity upon inflammatory challenge. Mechanistically, RNA‐sequencing and functional assays revealed enhanced mTORC1 signaling and glycolysis in Fxr −/− neutrophils. Consistently, pharmacological activation of FXR with INT‐747 significantly restrained the mTORC1‐glycolysis‐mediated proinflammatory responses in neutrophils from IBD patients. Our findings identify FXR as a critical regulator of neutrophil‐mediated mucosal inflammation via the mTORC1‐glycolysis pathway, highlighting its therapeutic potential in IBD.

1 November 2024 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
YZYuqiang Zhang
Yuqiang Zhang
PCPeijia Cong
Peijia Cong
BWBin Wang
Bin Wang
HLHaifeng Lian
Haifeng Lian
YZYuming Zhou
Yuming Zhou
Polyamine synthesis and abnormal regulation of B cell differentiation occur concurrently in various diseases. We investigated whether putrescine could suppress germinal center B cell (GCB) differentiation by inducing reactive oxygen species (ROS) generation. The results of flow cytometry analysis revealed that putrescine did not affect B cell apoptosis and cell cycle. The results of RT-qPCR and western blotting revealed that putrescine could inhibit CD79a phosphorylation rather than total expression. Using an O2K high-resolution respirometer, we illustrated that putrescine increased the oxygen consumption rate in the basal mitochondrial respiration stage, ATP-coupled respiration stage, and maximum respiration stage. Similarly, it also elevated ROS generation across stages in B cells and reduced the proportion of GCB cells. Meanwhile, ROS scavenging by SOD could reverse such inhibitory effects on GCB cells. We concluded that putrescine could inhibit the differentiation of GCB cells by reducing CD79a phosphorylation and increasing ROS levels in GCB cells.